FDA Clears IotaMotion’s Robotic CI Insertion System for Expanded Pediatric Use
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
A cochlear implant (CI) program in South Carolina has demonstrated how strategic workflow design, data-driven efficiency measures, and team-based care can dramatically expand access, improve patient satisfaction, and sustain rapid program growth in an underserved region.
Addressing in-person communication is no longer enough. Direct-to-ear audio streaming—via hearing aids, TV streamers, and emerging technologies like Auracast—reduces listening fatigue, improves recall and engagement, and enables people with hearing loss to more fully participate in online work and public venues.
Summary:Sonitus Medical and BHM have formed a strategic partnership to globally commercialize...
Despite significant advances in cochlear implant technology and expanded candidacy criteria, access to these life-changing devices remains limited, prompting professionals to find new ways to close the gap in care.
Envoy Medical received FDA approval to begin a study of its fully implanted CI, which uses the ear’s natural anatomy to capture sound.